SCHEMBL1284937

SCHEMBL1284937

CCOCc1cc2ccccc2o/c1=N\c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGXT P21549 1/20 0.40
NPC1 O15118 5/20 0.39
ALDH1A1 P00352 4/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
TP53 P04637 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 2/20 0.39
USP2 O75604 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
RAB9A P51151 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.36
MAOB P27338 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1284938 1.00 AGXT (0.40) AGXTNPC1ALDH1A1MAPTKDM4E
SCHEMBL1285392 0.90 CA12 (0.39) AGXTNPC1ALDH1A1MAPTKDM4E
SCHEMBL1285468 0.90 MAPT (0.40) AGXTALDH1A1MAPTKDM4ETP53
SCHEMBL1284490 0.90 MAPT (0.37) AGXTNPC1ALDH1A1MAPTKDM4E
SCHEMBL1284491 0.90 MAPT (0.37) AGXTNPC1ALDH1A1MAPTKDM4E
SCHEMBL1284660 0.90 MAOB (0.40) AGXTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1285467 0.90 MAPT (0.40) AGXTALDH1A1MAPTKDM4ETP53
SCHEMBL1284663 0.90 MAOB (0.40) AGXTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1285390 0.90 CA12 (0.39) AGXTNPC1ALDH1A1MAPTKDM4E
SCHEMBL1285014 0.89 AKR1B10 (0.45) NPC1ALDH1A1MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383843-B2 Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound KAOHSIUNG MEDICAL UNIVERSITY (TW) 2013-02-26 US disclosed
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND CYP3A7, CYP2A7, F7 AGXT 1115/4885NPC1 548/4885ALDH1A1 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.